| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Pathology, VAMC-Wayne State University, Detroit
2 From the Department of Medicine, UCLA School of Medicine, Los Angeles
3 From the Department of Pathology, UCLA School of Medicine, Los Angeles
Background: Marijuana and alkaloidal cocaine ("crack") are the two most commonly smoked substances in the United States after tobacco. While regular tobacco smoking has been found to be associated with extensive microscopic alterations in bronchial mucosa, little information is available concerning the effect of crack cocaine and marijuana on tracheobronchial histopathology.
Study objective: To determine the relative impact of smoked substances (cocaine, marijuana, and tobacco) alone and in combination on the histopathology of the tracheobronchial mucosa and to assess whether the effects of habitual smoking of two or more substances (cocaine, marijuana, and/or tobacco) are additive.
Design: Observational cohort study.
Subjects: Fifty-three nonsmoking control subjects (NS), 14 current, habitual smokers of crack cocaine only (CS), 40 current, regular smokers of marijuana only (MS), 31 regular smokers of tobacco only (TS), 16 current smokers of both cocaine and marijuana (CMS), 12 current smokers of both cocaine and tobacco (CTS), 44 current smokers of both marijuana and tobacco (MTS), and 31 current smokers of cocaine, marijuana, and tobacco (CMTS).
Methods: After preliminary screening evaluation, including a detailed respiratory and general health questionnaire and routine pulmonary function studies, subjects underwent fiberoptic bronchoscopy with endobronchial biopsies of the mucosa of the primary carina and randomly selected secondary or tertiary carinae. Biopsy specimens were processed for light microscopy, stained with hematoxylineosin or periodic acid-Schiff, and examined to assess epithelial, basement membrane, and submucosal alterations by one or two pathologists who were masked to the smoking status of the subject.
Results: Smokers of cocaine, marijuana, or tobacco alone all exhibited more frequent abnormalities than NS in 10 (CS) or all 11 (MS and TS) of the histopathologic features assessed. For most features, MS and TS showed significantly more frequent alterations than NS (p 
0.02), while CS showed significantly more frequent abnormalities than NS in only three features (p<0.05) and nearly significant differences from NS in two additional features (p 0.09). Alterations were noted most frequently in CTS (six features) and MTS (three features), while abnormalities were relatively infrequent in CMS. For 10 features, MTS had more frequent alterations than MS and TS. With a single exception, CMTS did not show more frequent alterations than CTS or MTS.
Conclusion: Marijuana and tobacco smoking each produces significant bronchial mucosal histopathology and the effects of marijuana and tobacco appear additive. Cocaine appears to lead to fewer significant bronchial mucosal alterations than marijuana or tobacco when smoked alone and does not add to the changes associated with marijuana. When smoked together with tobacco, however, cocaine appears to augment the bronchial injury caused by tobacco smoking.
Key Words: airway injury • bronchial mucosa • crack cocaine • histopathology • lung • marijuana • tobacco
Submitted on November 1, 1996
Accepted on January 23, 1997
This article has been cited by other articles:
|
|
 |
|
  R. Mehra, B. A. Moore, K. Crothers, J. Tetrault, and D. A. Fiellin The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med, July 10, 2006; 166(13): 1359 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Treasure and C. Tan Cannabis, pneumothorax and lung bullae: Author's reply. J R Soc Med, April 1, 2006; 99(4): 170 - 170. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Henry, W. L G Oldfield, and O. M. Kon Comparing cannabis with tobacco BMJ, May 3, 2003; 326(7396): 942 - 943. [Full Text] [PDF]
|
|
|
|
 |
|
 L. X. Zhu, S. Sharma, B. Gardner, B. Escuadro, K. Atianzar, D. P. Tashkin, and S. M. Dubinett IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity J. Immunol., April 1, 2003; 170(7): 3585 - 3591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Sarafian, S. Kouyoumjian, F. Khoshaghideh, D. P. Tashkin, and M. D. Roth Delta 9-Tetrahydrocannabinol disrupts mitochondrial function and cell energetics Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L298 - L306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Baldwin, R. Choi, M. D. Roth, A. H. Shay, E. C. Kleerup, M. S. Simmons, and D. P. Tashkin Evidence of Chronic Damage to the Pulmonary Microcirculation in Habitual Users of Alkaloidal ("Crack") Cocaine* Chest, April 1, 2002; 121(4): 1231 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Schantz and G.-P. Yu Head and Neck Cancer Incidence Trends in Young Americans, 1973-1997, With a Special Analysis for Tongue Cancer Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 268 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Roth, J. A. Marques-Magallanes, M. Yuan, W. Sun, D. P. Tashkin, and O. Hankinson Induction and Regulation of the Carcinogen-Metabolizing Enzyme CYP1A1 by Marijuana Smoke and Delta 9-Tetrahydrocannabinol Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 339 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Watson, J. A. Benson Jr, and J. E. Joy Marijuana and Medicine: Assessing the Science Base: A Summary of the 1999 Institute of Medicine Report Arch Gen Psychiatry, June 1, 2000; 57(6): 547 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Strang, J. Witton, and W. Hall Improving the quality of the cannabis debate: defining the different domains BMJ, January 8, 2000; 320(7227): 108 - 110. [Full Text]
|
|
|
|
 |
|
 Z.-F. Zhang, H. Morgenstern, M. R. Spitz, D. P. Tashkin, G.-P. Yu, J. R. Marshall, T. C. Hsu, and S. P. Schantz Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Epidemiol. Biomarkers Prev., December 1, 1999; 8(12): 1071 - 1078. [Abstract] [Full Text]
|
|
|
|
|
|
T. A. Sarafian, J. A. M. Magallanes, H. Shau, D. Tashkin, and M. D. Roth Oxidative Stress Produced by Marijuana Smoke . An Adverse Effect Enhanced by Cannabinoids Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1286 - 1293. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. P. Tashkin Effects of Marijuana on the Lung and its Defenses against Infection and Cancer School Psychology International, February 1, 1999; 20(1): 23 - 37. [Abstract] [PDF]
|
|
|
|
 |
|
 M. D. ROTH, A. ARORA, S. H. BARSKY, E. C. KLEERUP, M. SIMMONS, and D. P. TASHKIN Airway Inflammation in Young Marijuana and Tobacco Smokers Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 928 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. BALDWIN, D. P. TASHKIN, D. M. BUCKLEY, A. N. PARK, S. M. DUBINETT, and M. D. ROTH Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1606 - 1613. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
